Literature DB >> 12166601

The effects of glucose fluctuation on cognitive function and QOL: the functional costs of hypoglycaemia and hyperglycaemia among adults with type 1 or type 2 diabetes.

Daniel Cox1, Linda Gonder-Frederick, Anthony McCall, Boris Kovatchev, William Clarke.   

Abstract

It is traditionally believed that while acute hypoglycaemia has detectable negative consequences, such as unpleasant symptoms and cognitive-motor disruptions, acute hyperglycaemia is not associated with such consequences. However, recent research with adults affected by either type 1 or 2 diabetes mellitus demonstrates that relatively mild hyperglycaemia is associated with unpleasant symptoms and cognitive disruptions. Both hyperglycaemia and hypoglycaemia can be associated with patient experiences of physical, affective, and cognitive symptoms, as well as cognitive-motor disruptions. These effects can lead to impaired functioning and quality of life. Because these effects are different across patients, their significance can be difficult to appreciate. There is ample evidence that acute hypoglycaemia is a problem for both adults with type 1 and those with type 2 diabetes, and that mild and moderate hypoglycaemia reduce one's mental efficiency relative to euglycaemic performance. There is growing evidence that transient hyperglycaemia has similar negative effects. At relatively mild levels of extreme blood glucose--either hypoglycaemia or hyperglycaemia--cognitive efficiency may decay by a third. The impact of this effect will depend on the task the patient is dealing with at the time. If the person is engaging in a relatively dangerous task, such as driving a vehicle, significant consequences could follow. Both hypoglycaemia and hyperglycaemia have been demonstrated to have not only acute, but also chronic effects in patients with type 1 as well as those with type 2 diabetes. Although hypoglycaemia occurs at a lower rate among patients with type 2 diabetes than among those with type 1, the number of patients with type 2 diabetes is so large that even this low rate results in many persons being affected.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12166601

Source DB:  PubMed          Journal:  Int J Clin Pract Suppl        ISSN: 1368-504X


  18 in total

1.  Selective breeding for endurance running capacity affects cognitive but not motor learning in rats.

Authors:  Jan Wikgren; Georgios G Mertikas; Pekka Raussi; Riina Tirkkonen; Laura Äyräväinen; Markku Pelto-Huikko; Lauren G Koch; Steven L Britton; Heikki Kainulainen
Journal:  Physiol Behav       Date:  2012-01-20

2.  Pramlintide reduces the risks associated with glucose variability in type 1 diabetes.

Authors:  Boris P Kovatchev; John Crean; Anthony McCall
Journal:  Diabetes Technol Ther       Date:  2008-10       Impact factor: 6.118

3.  Better cognitive performance following a low-glycaemic-index compared with a high-glycaemic-index carbohydrate meal in adults with type 2 diabetes.

Authors:  Y Papanikolaou; H Palmer; M A Binns; D J A Jenkins; C E Greenwood
Journal:  Diabetologia       Date:  2006-03-01       Impact factor: 10.122

4.  Associations of serum glucagon levels with glycemic variability in type 1 diabetes with different disease durations.

Authors:  Ke Li; Wen-Jing Song; Xia Wu; Dan-Yang Gu; Pu Zang; Ping Gu; Bin Lu; Jia-Qing Shao
Journal:  Endocrine       Date:  2018-06-18       Impact factor: 3.633

Review 5.  Metrics for glycaemic control - from HbA1c to continuous glucose monitoring.

Authors:  Boris P Kovatchev
Journal:  Nat Rev Endocrinol       Date:  2017-03-17       Impact factor: 43.330

6.  Diabetes treatment patterns and goal achievement in primary diabetes care (DiaRegis) - study protocol and patient characteristics at baseline.

Authors:  Peter Bramlage; Christiane Binz; Anselm K Gitt; Michael Krekler; Tanja Plate; Evelin Deeg; Diethelm Tschöpe
Journal:  Cardiovasc Diabetol       Date:  2010-09-16       Impact factor: 9.951

7.  The median is not the only message: a clinician's perspective on mathematical analysis of glycemic variability and modeling in diabetes mellitus.

Authors:  Anthony L McCall; Boris P Kovatchev
Journal:  J Diabetes Sci Technol       Date:  2009-01

Review 8.  Treating type 1 diabetes: from strategies for insulin delivery to dual hormonal control.

Authors:  A L McCall; L S Farhy
Journal:  Minerva Endocrinol       Date:  2013-06       Impact factor: 2.184

9.  Metabolic syndrome is associated with impaired health-related quality of life: Lapinlahti 2005 study.

Authors:  Juhani Miettola; Leo K Niskanen; Heimo Viinamäki; Harri Sintonen; Esko Kumpusalo
Journal:  Qual Life Res       Date:  2008-08-31       Impact factor: 4.147

10.  Plasma Apolipoprotein E3 and Glucose Levels Are Associated in APOE ɛ3/ɛ4 Carriers.

Authors:  Anna K Edlund; Kewei Chen; Wendy Lee; Hillary Protas; Yi Su; Eric Reiman; Richard Caselli; Henrietta M Nielsen
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.